BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8277301)

  • 1. Dysfunctional attitudes in major depression. Changes with pharmacotherapy.
    Fava M; Bless E; Otto MW; Pava JA; Rosenbaum JF
    J Nerv Ment Dis; 1994 Jan; 182(1):45-9. PubMed ID: 8277301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
    Pedrelli P; Feldman GC; Vorono S; Fava M; Petersen T
    Psychiatry Res; 2008 Dec; 161(3):302-8. PubMed ID: 18976817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
    Farabaugh A; Mischoulon D; Schwartz F; Pender M; Fava M; Alpert J
    Depress Anxiety; 2007; 24(6):433-9. PubMed ID: 17086540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of dysfunctional attitudes and early maladaptive schemas: a 9-year follow-up study of clinically depressed subjects.
    Wang CE; Halvorsen M; Eisemann M; Waterloo K
    J Behav Ther Exp Psychiatry; 2010 Dec; 41(4):389-96. PubMed ID: 20452570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
    Kafka MP; Prentky R
    J Clin Psychiatry; 1992 Oct; 53(10):351-8. PubMed ID: 1429474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiently assessing negative cognition in depression: an item response theory analysis of the Dysfunctional Attitude Scale.
    Beevers CG; Strong DR; Meyer B; Pilkonis PA; Miller IR
    Psychol Assess; 2007 Jun; 19(2):199-209. PubMed ID: 17563201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine in the treatment of anger: an open clinical trial.
    Rubey RN; Johnson MR; Emmanuel N; Lydiard RB
    J Clin Psychiatry; 1996 Sep; 57(9):398-401. PubMed ID: 9746447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional attitudes and cognitive schemas in bipolar manic and unipolar depressed outpatients: implications for cognitively based psychotherapeutics.
    Goldberg JF; Gerstein RK; Wenze SJ; Welker TM; Beck AT
    J Nerv Ment Dis; 2008 Mar; 196(3):207-10. PubMed ID: 18340255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis.
    Farabaugh AH; Sonawalla SB; Fava M; Pedrelli P; Papakostas GI; Schwartz F; Mischoulon D
    Hum Psychopharmacol; 2006 Jun; 21(4):221-5. PubMed ID: 16783809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
    Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
    J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression.
    Quilty LC; McBride C; Bagby RM
    Psychol Med; 2008 Nov; 38(11):1531-41. PubMed ID: 18578895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional beliefs in bipolar disorder: hypomanic vs. depressive attitudes.
    Alatiq Y; Crane C; Williams JM; Goodwin GM
    J Affect Disord; 2010 May; 122(3):294-300. PubMed ID: 19773086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine efficacy in social phobia.
    Van Ameringen M; Mancini C; Streiner DL
    J Clin Psychiatry; 1993 Jan; 54(1):27-32. PubMed ID: 8428894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender, type of treatment, dysfunctional attitudes, social support, life events, and depressive symptoms over naturalistic follow-up.
    Zlotnick C; Shea MT; Pilkonis PA; Elkin I; Ryan C
    Am J Psychiatry; 1996 Aug; 153(8):1021-7. PubMed ID: 8678170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.